The growing success in genetic medicine has paved the way for a broader range of gene-based therapies and laid the foundation for next-generation technologies. Our flagship Gene Variant Analysis Platform is a precision medicine genomics software for the analysis and reporting of gene mutations and targeted therapies for various diseases. Comprehensive interpretation and reporting of gene sequencing results is no simple task, and that is why we designed a gene variant analysis platform alongside the genome research professionals to address the unmet needs of reducing the data analysis complexity in the field of precision medicine for cancer and other diseases.
Our flagship Gene Variant Analysis Platform is easily customizable to suit the needs of rapidly growing Gene Analysis based therapy healthcare market. While there are approved personalised therapies for cancer patients, this life-changing approach has laid a foundation on which treatments for many other disease conditions can be developed.
Our Gene Variant Analysis Platform can be best customised to address following disease areas
Personalised therapy for Cancer
Neonatal diagnostics/New-born screening (NBS)
Gene therapy for Reproductive medicine
Whole exome sequencing for inherited disorders
Hereditary/inherited Cancer and other syndrome diagnostics
Population genetic screening
Our Gene Variant Analysis Platform is best suitable for a genome sequencing laboratory that aspires to go beyond any limitations, implements a custom workflow, needs a consolidated access point to external knowledge sources. Our Gene Variant Analysis Platform maps to variety of Real-World Evidence (RWE) Clinical data sources and cancer mutation knowledgebases to present a personalised therapy option for individual patient.
We offer many pluggable products for your genome sequencing lab's needs including informatics pipelines, portal services, genomic Health Information Exchange (gHIE) and LIMS to name a few. Our platform is easily customizable to manifest your lab’s workflow and standard operating procedures (SOP) and a best fit to a CLIA/CAP and HIPAA compliance environments.
Our Gene Variant Analysis platform has been developed in collaboration with Precision Health Software Inc, USA
How our solutions impact human lives through precision therapy?
Whom we work with?
Speciality Hospitals
Genome Sequencing Labs
Pharma & Biotech companies
Diagnostics Labs